Life insurance with multiple sclerosis depends on MS type, disease progression, functional disability, and treatment regimen. Relapsing-remitting MS (RRMS) with stable disease on a disease-modifying therapy (DMT) is rated very differently from primary progressive MS with significant disability. The National MS Society estimates nearly one million Americans live with MS; carriers evaluate neurological function, relapse history, and mobility—not the diagnosis alone.
At Local Life Agents, we pre-screen MS files across 30+ A-rated carriers because neurological guidelines vary—and MS type determines which carriers will offer coverage.
Key Takeaways
- RRMS is the most insurable type. Relapsing-remitting MS with stable disease and no recent relapse often qualifies for Standard to Table 2.
- Progressive MS is rated heavily. Primary progressive or secondary progressive MS with disability typically means Table 4 or decline.
- Recent relapse means postpone. Applying within 12 months of a relapse usually means postpone until stability is documented.
- DMT use is expected. Disease-modifying therapies (Ocrevus, Tysabri, Tecfidera) are standard treatment—not a decline factor at most carriers.
- Disability status matters. SSA disability for MS usually means table ratings or decline at standard carriers.
Compare multiple sclerosis life insurance rates
Compare multiple sclerosis rates at carriers whose neurological guidelines match your MS type and disability status.
What do underwriters look for with multiple sclerosis?
Neurological underwriting for MS evaluates disease type, progression rate, and functional impact.
- MS type — Relapsing-remitting (RRMS) vs. primary progressive (PPMS) vs. secondary progressive (SPMS).
- Time since diagnosis — Recent diagnosis (under two years) is rated more cautiously than established disease with long stability.
- Relapse history — Number of relapses, date of most recent relapse, and recovery from each episode.
- Disability level — EDSS score (Expanded Disability Status Scale) if available; ambulation, vision, and cognitive function.
- Disease-modifying therapy — Current DMT (interferons, glatiramer, oral agents, infusion therapies) and treatment compliance.
- Functional status — Working full-time, driving, normal daily activities vs. assistive devices, wheelchair use, or home care.
- MRI findings — Lesion burden and recent MRI showing active disease vs. stable findings.
- Cognitive function — Documented cognitive impairment worsens offers.
- Bladder and bowel dysfunction — Common MS symptoms that signal disease progression.
Neurology records are essential: most recent visit, MRI summary, current DMT, and your neurologist's assessment of disease activity.
Application questions you'll see:
- What type of multiple sclerosis do you have (relapsing-remitting, primary progressive, secondary progressive)?
- When were you diagnosed?
- When was your last MS relapse?
- What disease-modifying therapy (DMT) are you currently taking?
- Do you have any disability from MS (vision problems, weakness, mobility issues)?
- Do you use assistive devices (cane, walker, wheelchair)?
- What is your EDSS score (if available)?
- Are you working? Have you taken disability leave for MS?
- When was your last MRI, and what did it show?
How does multiple sclerosis affect your life insurance rate class?
RRMS diagnosed more than two years ago, stable on DMT, no relapse in 12 or more months, ambulatory without assistive devices, and working full-time often qualifies for Standard to Table 2 at carriers with favorable neurological guidelines.
RRMS with one recent relapse (within 12 months) but otherwise stable typically means postpone until 12 months of stability, then Standard to Table 2.
RRMS with moderate disability (assistive device for walking, reduced work capacity) typically lands Table 2 to Table 4.
SPMS or PPMS with progressive disability, wheelchair dependence, or SSA disability usually means Table 4 or decline at standard carriers.
MS with significant cognitive impairment, blindness, or complete loss of ambulation typically means decline.
Can you get standard rates with multiple sclerosis?
Standard rates are possible for stable relapsing-remitting MS with no recent relapse and minimal disability. RRMS diagnosed more than two years ago, stable on DMT, no relapse for twelve months or longer, and full functional status often qualifies for Standard to Table 2 at carriers with favorable neurological guidelines. We've placed stable RRMS clients at Standard when disease activity is documented as controlled and work status is normal. The key is waiting twelve months after any relapse before applying and ensuring your neurologist documents disease type and stability. Progressive MS typically requires table ratings or alternative products. Understanding life insurance underwriting for neurological conditions helps you time your application.
Which carriers handle multiple sclerosis most competitively?
Neurological guidelines vary. Principal and Lincoln have historically been among the more favorable for stable RRMS on DMT. Prudential and John Hancock often work for mild MS with minimal disability. Progressive MS and significant disability need impaired-risk pre-screening.
Do not apply within 12 months of a relapse. Wait for documented stability with your neurologist before submitting a formal application.
Expert Tip: Document your MS type precisely
Clients say they have MS but cannot tell me if it is relapsing-remitting or progressive. Underwriters classify by type—RRMS with stable DMT is a different file than PPMS with disability. Get your neurologist to document MS type, date of last relapse, current EDSS if available, and disease activity status in writing before applying. That one document determines which carriers to pre-screen.
—Ryan Wood
Conclusion
Multiple sclerosis affects life insurance rates based on type and progression—not the diagnosis itself. Stable RRMS on DMT often qualifies for Standard at the right carrier; progressive MS with disability requires impaired-risk shopping. Independent agents pre-screen neurological files across 30+ A-rated carriers because MS guidelines vary enough that the same profile gets Standard at one company and decline at another.
If your MS is relapsing-remitting and stable, competitive rates are realistic with proper carrier matching. If progression has limited standard options, we pre-screen at carriers whose neurological guidelines fit and evaluate alternative products when needed. Return to our life insurance hub for product guides and coverage types.
Life Insurance
See what you'd pay — run your numbers across 30+ A-rated carriers in about 2 minutes.
Run My Numbers